11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia

Details for Australian Patent Application No. 2003251410 (hide)

Owner Merck & Co., Inc.

Inventors Balkovec, James M.; Olson, Steven H.; Zhu, Yuping

Agent Spruson & Ferguson

Pub. Number AU-B-2003251410

PCT Number PCT/US03/17890

PCT Pub. Number WO2003/104208

Priority 60/387,385 10.06.02 US

Filing date 6 June 2003

Wipo publication date 22 December 2003

Acceptance publication date 21 May 2009

International Classifications

C07D 249/00 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/433 (2006.01) - Thiadiazoles

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/48 (2006.01) Drugs for disorders of the endocrine system

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/14 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/387,385 10.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-B-2003251410

21 May 2009 Application Accepted

  Published as AU-B-2003251410

17 September 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003251411-STOP-COCK SUTURE CLAMPING SYSTEM

2003251409-MATERIAL ADAPTED TO DISSIPATE AND REDUCE VIBRATIONS AND METHOD OF MAKING SAME